The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit

Respiratory Care

Volumn 50, Issue 11, 2005, Pages 1451-1456

  McMullin, Bevin B ^a,b,e   Chittock, Dean R ^a   Roscoe, Diane L ^a   Garcha, Harjinder ^c   Wang, Lexin ^b   Miller, Christopher C ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHARLES STURT UNIVERSITY   (Australia)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d Pulmonox Medical Inc   (Canada)

^e Respiratory Services   (Canada)

Author keywords

Antimicrobial; Bacteria; Bactericidal; Nitric oxide; Nosocomial; Pneumonia

Indexed keywords

NITRIC OXIDE; ANTIINFECTIVE AGENT;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HOST CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INCUBATOR; INTENSIVE CARE UNIT; MALE; PNEUMONIA; VENTILATED PATIENT; ANALYSIS OF VARIANCE; BACTERIAL PNEUMONIA; BACTERIUM; CROSS INFECTION; DRUG EFFECT; GAS; INHALATIONAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; FEMALE; GASES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NITRIC OXIDE; PNEUMONIA, BACTERIAL; TREATMENT OUTCOME;

EID: 33644844842     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001;29(12):2303-2309.
2. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002;122(6):2183-2196.
3. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165(7):867-903.
4. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122(6):2115-2121.
5. Hubmayr RD, Burchardi H, Elliot M, Fessler H, Georgopoulos D, Jubran A, et al. Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia-Chicago, Illinois, May 2002. Intensive Care Med 2002;28(11):1521-1536.
6. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J. Type III protein secretion is associated with a poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002;30(3):521-528.
7. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant vs piperacillin-susceptible organism. Clin Infect Dis 2002;34(8):1047-1054.
8. Hayon J, Figliolini C, Combes A, Trouillet JL, Kassis N, Dombret MC, et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165(1):41-46.
9. Moncada S, Palmer RM, Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43(2):109-134.
10. Hurford WE. Inhaled nitric oxide. Respir Care Clin N Am 2002;8(2):261-279.
11. De Groote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infec Dis 1995;21(2 Suppl):S162-S165.
12. Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling. Crit Care Med;2000;28(4 Suppl):N37-N52.
13. Bogdan C, Rollinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev 2000;173:17-26.
14. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol 1983;46(1):198-202.
15. Fang FC. Perspectives series: Host/pathogen interactions: mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99(12):2818- 2825.
16. Tarr HLA. Bacteriostatic action of nitrates. Nature 1941;147(3727):417- 418.
17. Shank JL, Silliker JH, Harper RH. The effect of nitric oxide on bacteria. Appl Microbiol 1962;101:185-188.
18. Hoehn T, Huebner J, Paboura E, Krause M, Leititis JU. Effect of therapeutic concentrations of nitric oxide on bacterial growth in vitro. Crit Care Med 1998;26(11):1857-1862.
19. Webert KE, Vanderzwan J, Duggan M, Scott JA, McCormack DG, Lewis JF, Mehta S. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia. Crit Care Med 2000:28(7);2397-2405.
20. Jean D, Maitre B, Tankovic J, Meignan M, Adnot S, Brun-Buisson C, et al. Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearance. Crit Care Med 2002;30(2):442-447.
21. Ghaffari A, Neil DH, Ardakani A, Road J, Ghahary A, Miller CC. A direct nitric oxide gas delivery system for bacterial and mammalian cell culture. Nitric Oxide 2005;12(3):129-140.
22. Tamir S, Lewis RS, de Rojas Walker T, Deen WM, Wishnok JS, Tannenbaum SR. The influence of rate on the chemistry and biological effect of nitric oxide. Chem Res Toxicol 1993;6(6):895-899.
23. O'Reilly P, Hickman-Davis JM, McArdle P, Young KR, Matalon S. The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A. Mol Cell Biochem 2002;235(1-2):39-48.
24. Long R, Light B, Talbot JA. Mycobacteriocidal action of exogenous nitric oxide. Antimicrob Agents Chemother 1999;43(2):403-405.
25. Miller CC, Miller MK, Ghaffari A, Kunimoto B. Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study. J Cutan Med Surg 2004;8(4):233-238.
26. Keynes RG, Griffiths C, Garthwaite J. Superoxide-dependent consumption of nitric oxide in biological media may confound in vitro experiments. Biochem J 2003;369(Pt 2):399-406.
27. Food and Drug Administration Approval of NDA 20-846 INOmax nitric oxide gas 1999. http://www.fda.gov/cder/rdmt/ndaaps98cy.htm. Accessed August 18, 2005.
28. Young JD, Dyar O, Xiong L, Howell S. Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide. Intensive Care Med 1994;20(8):581-584.
29. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284(5418):1318-1322.